Stefan Eirefelt

801 total citations
23 papers, 477 citations indexed

About

Stefan Eirefelt is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Dermatology. According to data from OpenAlex, Stefan Eirefelt has authored 23 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Pharmaceutical Science and 6 papers in Dermatology. Recurrent topics in Stefan Eirefelt's work include Inhalation and Respiratory Drug Delivery (9 papers), Dermatology and Skin Diseases (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). Stefan Eirefelt is often cited by papers focused on Inhalation and Respiratory Drug Delivery (9 papers), Dermatology and Skin Diseases (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). Stefan Eirefelt collaborates with scholars based in Sweden, Denmark and Austria. Stefan Eirefelt's co-authors include Ursula Hultkvist Bengtsson, Ann Tronde, Fredrik Johansson, Magnus Dahlbäck, Hans Lennernäs, P. Staffan Karlsson, Åke Svensson, K. O. Nordell, Per Gerde and George R. Baran and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Stefan Eirefelt

23 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Eirefelt Sweden 14 181 150 80 73 71 23 477
Patricia Almudéver Spain 10 127 0.7× 68 0.5× 119 1.5× 70 1.0× 98 1.4× 15 403
Jarmo K. Laihia Finland 15 38 0.2× 17 0.1× 36 0.5× 197 2.7× 119 1.7× 38 571
Peter J. Conroy United States 14 135 0.7× 15 0.1× 31 0.4× 6 0.1× 102 1.4× 28 491
W. Schalla Germany 10 9 0.0× 63 0.4× 37 0.5× 145 2.0× 40 0.6× 19 338
Xingxing Li China 11 41 0.2× 47 0.3× 78 1.0× 15 0.2× 172 2.4× 33 383
Tatiana Bandaletova United Kingdom 13 25 0.1× 8 0.1× 80 1.0× 46 0.6× 79 1.1× 16 373
Yongmei Hao China 6 17 0.1× 238 1.6× 13 0.2× 62 0.8× 127 1.8× 13 446
Juraj Hegyi Slovakia 7 20 0.1× 7 0.0× 32 0.4× 140 1.9× 45 0.6× 10 384
G.B. Fregnan Italy 12 102 0.6× 29 0.2× 64 0.8× 4 0.1× 74 1.0× 42 395
Joshua D. Williams United States 13 39 0.2× 13 0.1× 12 0.1× 168 2.3× 91 1.3× 21 453

Countries citing papers authored by Stefan Eirefelt

Since Specialization
Citations

This map shows the geographic impact of Stefan Eirefelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Eirefelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Eirefelt more than expected).

Fields of papers citing papers by Stefan Eirefelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Eirefelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Eirefelt. The network helps show where Stefan Eirefelt may publish in the future.

Co-authorship network of co-authors of Stefan Eirefelt

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Eirefelt. A scholar is included among the top collaborators of Stefan Eirefelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Eirefelt. Stefan Eirefelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eirefelt, Stefan, Martin Stahlhut, Naila Svitacheva, et al.. (2022). Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment. Scientific Reports. 12(1). 1501–1501. 9 indexed citations
2.
Feizpour, Amin, et al.. (2020). Label-Free Quantification of Pharmacokinetics in Skin with Stimulated Raman Scattering Microscopy and Deep Learning. Journal of Investigative Dermatology. 141(2). 395–403. 32 indexed citations
3.
Eirefelt, Stefan, Fredrik Johansson, Thomas Birngruber, et al.. (2020). Evaluating Dermal Pharmacokinetics and Pharmacodymanic Effect of Soft Topical PDE4 Inhibitors: Open Flow Microperfusion and Skin Biopsies. Pharmaceutical Research. 37(12). 243–243. 13 indexed citations
4.
Dack, Kevin N., et al.. (2020). Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology. Bioorganic & Medicinal Chemistry Letters. 30(17). 127402–127402. 6 indexed citations
5.
6.
Gerde, Per, et al.. (2017). Dissolv It : An In Vitro Method for Simulating the Dissolution and Absorption of Inhaled Dry Powder Drugs in the Lungs. Assay and Drug Development Technologies. 15(2). 77–88. 39 indexed citations
7.
Ohanyan, Tatevik, Nicole Schoepke, Stefan Eirefelt, et al.. (2017). Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant. Acta Dermato Venereologica. 98(1). 26–31. 48 indexed citations
8.
Sjövall, Peter, Tanja M. Greve, Kristian Møller, et al.. (2014). Imaging of Distribution of Topically Applied Drug Molecules in Mouse Skin by Combination of Time-of-Flight Secondary Ion Mass Spectrometry and Scanning Electron Microscopy. Analytical Chemistry. 86(7). 3443–3452. 47 indexed citations
9.
Eirefelt, Stefan, et al.. (2008). Short Inhalation Exposures of the Isolated and Perfused Rat Lung to Respirable Dry Particle Aerosols; the Detailed Pharmacokinetics of Budesonide, Formoterol, and Terbutaline. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(2). 169–180. 22 indexed citations
10.
Johnson, Jill R., et al.. (2008). Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction. American Journal of Physiology-Lung Cellular and Molecular Physiology. 295(5). L780–L788. 18 indexed citations
11.
Middleton, Brian, et al.. (2007). An Optimized Automated Assay for Determination of Metabolic Stability Using Hepatocytes: Assay Validation, Variance Component Analysis, and In Vivo Relevance. Assay and Drug Development Technologies. 5(3). 403–416. 17 indexed citations
12.
Tronde, Ann, George R. Baran, Stefan Eirefelt, Hans Lennernäs, & Ursula Hultkvist Bengtsson. (2002). Miniaturized Nebulization Catheters: A New Approach for Delivery of Defined Aerosol Doses to the Rat Lung. Journal of Aerosol Medicine. 15(3). 283–296. 38 indexed citations
13.
Johansson, Fredrik, et al.. (2002). Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate. European Journal of Pharmaceutical Sciences. 17(1-2). 63–71. 56 indexed citations
14.
Dahlbäck, Magnus, Stefan Eirefelt, Kjell Bäckström, et al.. (2002). Enhanced Insulin Absorption in the Rabbit Airways and Lung by Sodium Dioctyl Sulfosuccinate. Journal of Aerosol Medicine. 15(1). 27–36. 9 indexed citations
15.
16.
Andersson, Sven, et al.. (1995). Regulatory Effects of Aerosolized Budesonide and Adrenalectomy on the Lung Content of Endothelin-1 in the Rat. Respiration. 62(1). 34–39. 5 indexed citations
17.
Dahlbäck, Magnus & Stefan Eirefelt. (1994). Total Deposition of Fluorescent Monodisperse Particles in Rats. The Annals of Occupational Hygiene. 6 indexed citations
18.
Eirefelt, Stefan, et al.. (1992). Selective aerosol delivery to intubated rats; a comparison with nose only exposure. Journal of Aerosol Science. 23. 491–494. 5 indexed citations
19.
Dahlbäck, Magnus, et al.. (1989). Total deposition of evans blue in aerosol exposed rats and guinea pigs. Journal of Aerosol Science. 20(8). 1325–1327. 9 indexed citations
20.
Karlsson, P. Staffan, K. O. Nordell, Stefan Eirefelt, & Åke Svensson. (1987). Trapping efficiency of three carnivorous Pinguicula species. Oecologia. 73(4). 518–521. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Almudéver Breakdown of academic impact, for papers by Jarmo K. Laihia Breakdown of academic impact, for papers by Peter J. Conroy Breakdown of academic impact, for papers by W. Schalla Breakdown of academic impact, for papers by Xingxing Li Breakdown of academic impact, for papers by Tatiana Bandaletova Breakdown of academic impact, for papers by Yongmei Hao Breakdown of academic impact, for papers by Juraj Hegyi Breakdown of academic impact, for papers by G.B. Fregnan Breakdown of academic impact, for papers by Joshua D. Williams
Rankless by CCL
2026